Oncologist said OncotypeDX unnecessary - really???
Hi! I’m brand new to this board and am so thankful for all of you here as you all have been a great resource and a huge source of comfort to me during this crazy and scary time!
1 1/2 weeks out from Surgery (sentinel node biopsy and double mastectomy) and spoke briefly to my Oncologist yesterday regarding my full post-surgery path report. Will have more details in a couple days at my appt to discuss treatment options with him.
Before my surgery, I pushed the issue of possibility of OncoDX and/or MammaPrint and said we’d have to wait until after surgery to see if that was even necessary or if it makes sense to have the testing done. Well, yesterday on our phone conversation he said that the testing was not necessary and this is what I’m assuming why, is because a had 1 positive lymph node out of 7. He advised that chemo is necessary and radiation also a possibility.
I am going to get a second opinion, but I know that OncoDX is used highly for those with DCIS, but in reading other boards here, I see that a lot of you with IDC and lymph node involvement got the OncoDX so am a little worried that my Oncologist dismissed this. Again, I need to preface this in that I had a quick conversation with him yesterday because my appt with him to discuss my full path report was set for Monday, but I did not want to wait until then to get my initial results and his initial, overall feedback so he may have other reasons for backing up his statement that having this testing was not worthwhile and would not change the treatment plan.
Should I be concerned that he is not recommending this important genetic test? Really freaked out and scared with the thought of chemo and/or radiation. Thank you in advance
Comments
-
The oncotype test is an analysis of your specific tumor (different from genetic testing for known genetic markers). My surgeon submitted the tissue for mine, not my oncologist. I would get a second opinion if it were me. My test came back with low likelihood of recurrence and if not for the # of lymph nodes with cancer, I would have been a candidate to skip chemo. But my numbers did lead my oncologist to order less chemo than if my scores had indicated a higher likelihood of recurrence.
-
Hi DTR and welcome to Breastcancer.org,
In addition to the helpful advice Runrcrb provided, you may be interested in checking out the main Breastcancer.org site's page on Oncotype DX testing.
We hope this helps and we look forward to hearing more from you soon!
--The Mods
-
I would certainly get the test done. Knowledge is power, the more the better.
-
If you are ER and PR positive and Her2- you should definitely have one of those tests. Otherwise, how could he possibly know for certain that chemo would help? What was the grade and type of tumor?
-
Some oncologist are really aggressive when you have that positive lymph node. Is there any chance your cells are grade 3?
-
Thank you all for your responses so far! Grade 2 (I had 2 tumors) and am ER/PR+, HER 2-.
-
I was stage IIA and grade 2 with one lymph node positive. My oncologist ordered a Mammoprint and said the chemo decision would be based on that. It came back "high risk" and I did have chemo. The point is that if lymph node involvement alone were the deciding factor, she would not have ordered the Mammoprint which showed if my particular tumor would respond to chemo. I read an article recently that said underarm lymph node involvement is an indication of risk but that the possibility of distant mets is not determined by underarm lymph node involvement. He described it as having a speeding car and removing the speedometer: removal won't slow the car down. I believe it used to be that the Oncotype test was not used if even one lymph node was positive but that has changed and the test is used even if a lymph node is positive but I do know that Mammoprint test is used with lymph involvement. If on the other hand you are grade 3, that alone might warrant chemo without further testing. So I agree with the advice above to get a second option from an oncologist.
-
Polly413 -Very much appreciate your response/feedback! Hope you are doing well now
-
Thank you, DTR808, for starting this topic. I am just about a week out of my lumpectomy and sentinel node biopsy (clean margins, clean nodes). I have IDC, ER+, PR-, HER2-. And I too want to have the oncotype testing done. My surgeon had indicate that it would be the medical oncologist who would order the test. (I meet with surgeon, med onco, and radiation onco in a couple of days.) I REALLY want to have this additional piece of information about recurrence.
But I'm not sure how hard I can push for the testing or if I can insist on it. I'm the customer, right?
-
Hi all. Just chiming in to say that if you meet the criteria, definitely push for the Oncotype DX test, both with your MO and with your insurance company. It's a pain for doctors to order, since it requires the surgery, oncology, pathology and finance offices of the hospital to work together (smile), but it is a solid test that provides good data.
Here's some info from the main part of this website - it reflects the thinking that the test is not necessary if there is lymph node involvement, which is what makes insurance coverage hard and doctors hesitant:
Who is eligible for the Oncotype DX test?
You may be a candidate for the Oncotype DX test if:
- you've recently been diagnosed with stage I or II invasive breast cancer
- the cancer is estrogen-receptor-positive
- there is no cancer in your lymph nodes (lymph-node-negative breast cancer)
- you and your doctor are making decisions about chemotherapy.
Most early-stage (stage I or II), estrogen-receptor-positive breast cancers that haven't spread to the lymph nodes are considered to be at low risk for recurrence. After surgery, hormonal therapies such as an aromatase inhibitor or tamoxifen are prescribed to reduce the risk that the cancer will come back in the future. Whether or not chemotherapy is also necessary has been an area of uncertainty for patients and their doctors.
If you've been diagnosed with early-stage, estrogen-receptor-positive breast cancer, the Oncotype DX test can help you and your doctor make a more informed decision about whether or not you need chemotherapy. (Some research also suggests the test may help postmenopausal women with estrogen-receptor-positive breast cancer that has spread to the lymph nodes make chemotherapy decisions. Talk to your doctor if you are in this group.)
You also may be a candidate for the Oncotype DX test if:
- you've recently been diagnosed with DCIS
- you're having lumpectomy to remove the DCIS
-
Dtr808- My onc also did not run the Oncotype for me, she said because I was young with a positive node, chemo was a given. I got a second opinion at Dana Farber and they were the ones who sent it out for testing. It came back low, so I chose to skip chemo, but I did have to do rads because of the positive node. You don’t mention your age, but that may also play a role. There are some docs who don’t put a lot of faith in the Oncotype either, so it could be that
-
Just want to mention that a pretty large percentage of grade 3's= around 30%= have low Oncotype scores. I had grade 3 with LVI and my score was 8- no chemo. (It has been more than 3 years and sometimes I am still worried about such strong reliance on one test.)
The company that puts out the Oncotype Dx, Genomic Health, has folks on the phone to answer questions, if that helps.
-
cpeachymom- I'm 44, so l guess that's considered a young age to be diagnosed with BC.
Windingshores- thank you! Great idea! I will call!
PatsyKB - yes! We need to make sure we're our own best advocate!
Thank you all for the replies! First day on the forum and already feeling extremely uplifted by the support. I find myself in waves of sadness and depression - it helps to talk to others who understand exactly what I'm going through. :
-
Good morning, oncotype threads always catch my attention. Winding shores, I agree about the strong reliance on one test. I look at is as another piece of the puzzle. My oncotype was ordered by my surgeon and was sent 3 days later , after final path was done at the hospital. Like you said, Grade 3s with LVI can have a low oncotype. I had stage 1, grade 1 ( mitoitc, nuclei -1, ki 67- 24% ...which is confusing given my stage 1), clear margins and nodes neg but oncotype score of 27. PR 3% is what raised my score I believe. It all boils down to choice once you consider ALL of your information. Sometimes there is enough information where oncotype may not be needed, just ask. 27 was too close to high risk for me so chose to bust out the 4 rounds of chemo. Another member on our forum had a score of 31 opted out of chemo, took AIs for awhile and is many years out!!!. Never be afraid about being your own advocate. I remember what my surgeon said. "This is YOUR cancer and you have the right to understand it" as much as we can anyway.
-
I asked for an oncotypeDX for my second b.c....7mm and grade 3 but my oncologist said my treatment recommendation would be the same....no chemo, no rads, and I had a mastectomy....no nodes, no LVI. I always worry about the grade 3 bit myself. But it is done and over. So I worry not so much so it doesn't ruin my life that has been saved. I agree that you should always be your own advocate, as much as many doctors dislike this. As long as you are using reliable sources for information, it should be a welcome addition to a doctor's recommendations.
-
Oncotype DX criteria includes that it can be used for patients with 0 to 3 positive nodes.
Saying that it is only available for node negative patients is incorrect. I had 2 positive nodes, got the test, (insurance paid 100%), and avoided chemo because of a low score.
-
I am not sure why my MO ordered a Mammaprint instead of Oncotype. I have read that some doctors consider Oncotype unreliable but I was satisfied with the Mammaprint recommendation and didn't ask my doctor why she chose that. Sometimes doctors may not recommend something because they know your insurance won't cover it so I sometimes ask if that is a factor in whatever decision is being made for me but didn't about this test. ( I am on Medicare and AARP United Healthcare Ins.) Mammaprint gives you a high risk or a low risk rating -- no in-betweens. I understand that one reason some doctors do not order Oncotype is that there is a range in the middle of the numbers where the effect of chemo is unclear and Mammaprint was developed to remove that issue. I don't know. My risk although "'high", was 14 on a scale of 1 to 100 so consider it "low" high risk if you see what I mean. But if I had been "low risk" with a score of 99 on a scale of 1 to 100 low risk (with 1 being the lowest) and was thus "high" low risk, I might have worried about skipping chemo. It is confusing for sure.
DTR808: to answer your question about how I am doing, just had my one year post diagnosis mammogram and there was a questionable "spot" but likely just a benign bit of scar tissue. Will have a 6 month recheck. So doing okay at this point. Thanks for asking. Polly
-
My oncologist said the research is better with mammaprint compared to the other tests. She said eventually standard of care will catch up (and since then it was added to the official guidelines as an option) but that many docs are still ordering certain tests because it is what they are comfortable with.
-
Polly, i understand what you are saying about the high low thing, it is confusing! There is a gray area in the oncotype. The tailor x study results come out very soon. In that study, I believe, but not certain that 26 is considered high. It did make my decision (27..so "high" intermediate range ) to be a little easier than had I fallen in the lower 20 range. Confusing for sure!
-
I posted the following on another topic but since so many of you kindly replied with your feedback, I thought I’d update those who were curious about what ultimately cameof my situation here.
After my original post above, I pushed my MO to order both the OncoDX and Mammaprint tests (which both cane back low). I also went and got a second opinion. Coincidentally, my original MO advised that I could forego chemo (go figure), but my second opinion MO advised that I could benefit a little from it (ultimately that was her suggestion) but could also choose to forego it (which she was ok with but if she had to choose, she told me she’d prefer I do it).
I had a connection through a coworker to get access to Laura Van’t Veer (inventor of Mammaprint), so thought I’d be crazy to not call in this favor to connect with her and get he feedback. Here goes...
———-
Thanks again to all who've provide their feedback regarding my original post here.
I have finally gotten my "3rd and final opinion" from Laura Van't Veer (inventor of Mammaprint) and I'm excited to say, nooooooo chemo!!!!!
The main takeaway from her feedback to me was that while from reading my path, the characteristics of my tumor were intermediate (grade 2, stage 2) so while one could interpret this to be a grey are or mid-range wanting to err on the side of caution and advise that chemo should be the course of treatment, looking at the biology of the tumor itself ismore important and more, in her words, "meaningful".
I didn't want to copy and paste her entire email to me as it's quite lengthy, but wanted to at least on some of the more important parts that others might be able to learn from or takeaway here. Keep in mind, her life's work has been and continues to be BC research through the lens of a molecular biologist therefore, she is always on the cutting edge of data research:
1 node positive, is not negative of course, but one is recognizing more and more that up to 3 positive nodes is leaning for risk of recurrence more towards negative, certainly if only 1 is positive.
Oncotype is 16, which is at the border of low to intermediate. The Tailor X trial just showed that this score, 16, patients did not benefit from chemotherapy. Though there is some debate about whether that is true for women under 50. However, there might be a little benefit, but that is not very much.
MammaPrint is +0.339, which is clearly low risk. The Mindact trial has shown that even for women who have 'high clinical risk features', but their tumor biology is MammaPrint low risk can forego chemotherapy. Their benefit is clinical not meaningful, and not more than 1-2% (meaning that of 100 such patients treated by chemotherapy, up to 2 will benefit, but according to preset criteria in the trial, that would be outweighed by the (short and long term) negative side effect of chemo.
My conclusion based on level 1 evidence data:
The patient is considered clinical high risk (for recurrence), but both Tailor X (Oncotype Low/lower end of Intermediate), and Mindact (MammaPrint low risk), have shown that chemotherapy does not give any clinical meaningful benefit. For this exact situation the ASCO organization recommends that patients can consider to forego chemotherapy.———-
Lastly, she confirmed that my proposed chemo of TCx4, while on the lighter side of chemo, was still too much in her opinion. The proposed hormonal therapy for 5-10 years she thought was justified at five years but should revisit thereafter whether or not the additional 5 years would be necessary.
I am hoping this helps at least one person or gives someone the peace of mind knowing they made a good decision for themselves to forego chemo based on the unique biological characteristics of their tumor. My hope is that soon, more and more doctors will acknowledge this and wrap their arms around this not-so cookie cutter approach and that BC is not a "one size fits all" deal. If I had just accepted what was advised during my first, surgical path follow up meeting with my first MO (that I would def need chemo and that the OncoDX and Mammaprint tests "weren't necessary because I was young and LN positive"), then I would be one TC infusion down out of 4, by now.
Another reminder that YOU are your best advocate! Cheers ladies!!!
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team